Aida Trivic
Adult Health · Saint Louis, MONPI 1386971323
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,638 of the $7,519 with a category attached, or 75.0%. 36 manufacturers reported payments, led by Gilead at 38.2% of the total. 2025 is the largest year on record at $3,051, 5.8 times the $523 reported in 2021. Among adult health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $27.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3K
- Viiv Healthcare Company$634
- Napo Pharmaceuticals Inc$617
- Pfizer$386
- Merck$322
- Johnson & Johnson$302
- plus $2K from 30 others
What the payments were for
- Consulting fees$1,75023%
- Speaking & faculty fees$320%
- Food & beverage$5,63875%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 36 | $2,874 |
| Viiv Healthcare Company | 33 | $634 |
| Napo Pharmaceuticals Inc | 23 | $617 |
| Pfizer | 22 | $386 |
| Merck | 15 | $322 |
| Johnson & Johnson(2 entities) | 17 | $302 |
| AbbVie | 12 | $246 |
| Novo Nordisk | 15 | $245 |
| EMD Serono, Inc. | 8 | $168 |
| Abbott | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $137 |
| Lilly USA, LLC | 6 | $121 |
| Antares Pharma, Inc. | 5 | $111 |
| Janssen Products, LP | 1 | $99 |
| Boehringer Ingelheim | 5 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| GSK | 4 | $80 |
| Amgen | 6 | $79 |
| AstraZeneca | 5 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Theratechnologies Inc. | 3 | $69 |
| Tris Pharma Inc | 4 | $66 |
| Sanofi-aventis U.S. LLC | 2 | $61 |
| Halozyme Inc | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| Hologic Sales And Service, LLC | 3 | $52 |
| Acerus Pharmaceuticals Corporation | 2 | $50 |
| Almatica Pharma LLC | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $30 |
| Optinose US, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,519 in reported general payments places this provider in the 90th percentile of 555 adult health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $48,655 |
| MounjaroTirzepatide | 13 | $13,802 |
| OzempicSemaglutide | 11 | $9,160 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,924 |
| Estradiol | 36 | $3,104 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,530 |
| ValacyclovirValacyclovir Hcl | 12 | $852 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $489 |
| Omeprazole | 30 | $432 |
| Fluticasone Propionate | 17 | $409 |
| Atorvastatin Calcium | 61 | $390 |
| Pantoprazole Sodium | 27 | $380 |
| Amitriptyline Hcl | 27 | $332 |
| Baclofen | 14 | $321 |
| Buspirone Hcl | 27 | $317 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $2,874 | $48,65512 claims |
| Lilly USA, LLCMounjaro | $121 | $13,80213 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $70 | $11,45426 claims |
| Novo NordiskOzempic | $245 | $9,16011 claims |
| Almatica Pharma LLCSertraline Hcl | $35 | $5414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 555 adult health providers in Missouri.
Other adult health in Saint Louis
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
- Jennifer SpeiserSaint Louis$27K
- Michele NobsSaint Louis$15K
- Lisa Koester WiedemannSaint Louis$14K
- Erin DoserSaint Louis$13K
- Marcee StegemeierSaint Louis$12K
- Heather PophamSaint Louis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.